Initiatives in the Medical Field: Specific efforts
Supporting telemedicine and improving efficiency in examinations and diagnosis with superior imaging technology
Japan, recognized as a country with advanced medical care, is experiencing a surging awareness of health issues across the general population as well as rising social strains in the wake of such problems as an overall shortage and uneven distribution of doctors, a falling birthrate and an aging population. Medical care in this environment must support the early detection and treatment of disease, and diagnostic imaging is a tool for meeting these needs. On the other hand, higher performance diagnostic imaging systems as well as the widespread application of new examination tools such as CT, PET, MRI and electronic endoscopes are generating burgeoning volumes of patient data. Consequently, the health care environment in Japan is increasingly drawing upon database technologies for sharing diagnostic imaging data and leveraging network capabilities to enhance telemedicine services.
As a provider of comprehensive diagnostic imaging solutions, Fujifilm is aggressively supplying systems and equipment to the front line of medical care. SYNAPSE, our medical imaging and information management system, which commands the top share of the domestic market, and C@Rna, a medical network service, play key roles. Beyond their function as comprehensive diagnostic systems that archive, integrate and network medical images, they also improve the efficiency of medical facilities operations. Furthermore, our telemedicine network service enhances the quality of local health care and supports new medical options, such as simplifying the process for gaining second opinions.
By taking advantage of the proprietary technical capabilities it has built up over the years, including image processing and precision optical technologies, Fujifilm has actively released various medical systems and equipment. These new products cause much less physical discomfort for the patient and are more environmentally friendly. In addition to the worldwide market-leading FCR (Fuji Computed Radiography) digital X-ray diagnostic imaging system and our electronic endoscope system, we have recently been working to further expand the field of diagnostic imaging with a fully digital ultrasonograph system and diagnostic radiopharmaceuticals. Linking these with SYNAPSE will provide powerful solutions for improving the efficiency and speed of examinations and diagnosis with even greater precision. Fujifilm intends for these advances to further the quality of medical care around the globe as well as in Japan.
Improved breast cancer detection through FCR Digital Mammography CAD
Fujifilm started early on doing research into image processing to support breast cancer diagnosis. The company has helped to raise the efficiency and quality of diagnostic imaging by developing an FCR-based digital mammography system combining high-definition reading technology suitable for breast cancer screening with our own cutting-edge image processing technologies. The number of those undergoing breast cancer screening has been rising, requiring massive diagnostic work by physicians. Fujifilm developed and introduced FCR Digital Mammography CAD, a computer-assisted breast cancer detection support system, in February 2008. Fujifilm became the first domestic manufacturer in Japan to obtain approval for a CAD system under the Pharmaceutical Affairs Law from the Ministry of Health, Labor and Welfare. Fujifilm has also developed a proprietary detection algorithm for this system based on a wealth of cases from within Japan and has been able to achieve a high rate of detection for areas showing characteristics of breast cancer, including microcalcifications and masses. A high detection rate supports physicians in their readings of images.
Today, an estimated one out of every 20 to 30 Japanese women develops breast cancer, the incidence of which is rising every year around the world. However, in addition to selfexaminations, regular mammography screening can detect breast cancer at an early stage, when 90% of cases can be cured. Fujifilm will continue to strengthen its efforts to improve the early detection of breast cancer and provide greater accuracy in diagnosis.
![[Photo]FCR Digital Mammography CAD](pack/images/activity_img_01.jpg)
FCR Digital Mammography CAD
Saving more lives from breast cancer with the Pink Ribbon Campaign
![[Logo]Pink Ribbon](pack/images/activity_img_02.jpg)
Pink Ribbon
Since 2003, the Fujifilm Group has been a steadfast supporter of the Pink Ribbon Campaign, which raises public awareness of the importance of early detection, diagnosis and treatment of breast cancer. Fujifilm and FUJIFILM Medical Co., Ltd. actively participated in Pink Ribbon Festivals held on October 7, 13 and 28, 2007, in Since 2003, the Fujifilm Group has been a steadfast supporter of the Pink Ribbon Campaign, which raises public awareness of the importance of early detection, diagnosis and treatment of breast cancer. Fujifilm and FUJIFILM Medical Co., Ltd. actively participated in Pink Ribbon Festivals held on October 7, 13 and 28, 2007, inTokyo, Sendai, and Kobe, respectively. In Tokyo and Kobe, the companies served as special sponsors for the Pink Ribbon Smile Walk 2007, the festival's main event, and both companies cooperated in the Sendai event.
Around the same time, we held “Pink, Pink, Pink!,” a photo exhibition of 12 leading photographers, at FUJIFILM SQUARE, the complex showroom in the Tokyo Midtown. The exhibition attracted a large number of visitors and heightened their awareness of breast cancer and the Pink Ribbon Campaign.
We also held a seminar for Fujifilm employees to promote awareness of breast cancer in the Tokyo area on September 11, 2007, featuring Ms. Tomoko Nakanishi of the Asahi Shimbun Company, who has encouraged the participation of many major organizations in the Pink Ribbon Campaign, and Dr. Hideko Hiramatsu, Hiramatsu Lady's Clinic. Over 200 men and women attended the seminar.
![[Photo]Pink Ribbon Festivals](pack/images/activity_img_03.jpg)
Pink Ribbon Festivals
![[Photo]“Pink, Pink, Pink!” photo exhibition](pack/images/activity_img_04.jpg)
“Pink, Pink, Pink!” photo exhibition
![[Photo]Employees attending Breast Cancer Screening Seminar](pack/images/activity_img_05.jpg)
Employees attending Breast Cancer Screening Seminar
Pink Ribbon Campaign overseas
![[Photo]Pink Ribbon Campaign display tent at the Longs Drugs LPGA Tournament](pack/images/activity_img_06.jpg)
Pink Ribbon Campaign display tent at the Longs Drugs LPGA Tournament
![[Photo]Website calling for one million women in the U.S. to schedule breast cancer examinations](pack/images/activity_img_07.jpg)
Website calling for one million women in the U.S. to schedule breast cancer examinations
In fiscal 2007, the Pink Ribbon Campaign was also actively conducted overseas. FUJIFILM U.S.A., Inc. and FUJIFILM Medical Systems U.S.A., Inc., in collaboration with Longs Drugs, promoted breast cancer awareness at the annual Longs Drugs LPGA Tournament as well as through sales campaigns for QuickSnap Pink that carried the “Images of Health” message throughout October in more than 470 Longs Drugs stores in California, Hawaii and Nevada. FUJIFILM U.S.A. donated 10% of sales (US$2,000) to the National Breast Cancer Foundation. The companies have been continuing to raise public awareness of the life-saving importance of mammography to detect breast cancer through a website that is designed to motivate over one million women to get a mammogram.
Aiding in the early detection of lesions, transnasal endoscopes support diagnosis using FICE
The development of our transnasal endoscope was made possible by fully leveraging FUJINON's lens and precision optical technologies and Fujifilm's Super CCD technology. The endoscope tip, with a diameter of 5.9 mm, can be inserted through the nose. Patients examined with this device experience much less discomfort, such as nausea during insertion, compared with conventional endoscopes that are inserted through the mouth, and are able to continue communicating with physicians during the examination. Consequently, these units have become very popular with both physicians and patients and have already been introduced into a large number of medical facilities worldwide.
Because its thin scope facilitates observation of target areas from many different angles, the transnasal endoscope is suitable for diagnostic examinations of narrow organs, such as the esophagus, in addition to the stomach. Recently, our transnasal endoscopes have also been used for the early detection of lesions in areas ranging from the mouth to the stomach including cancers of the throat and the esophagus as well as reflux esophagitis.
FICE (FUJI Intelligent Chromo Endoscopy: Imaging diagnosis based on spectral estimation technology) improves the accuracy of diagnostic endoscopy. Through optical image processing, FICE facilitates ready identification of subtle lesions that are difficult to detect through ordinary endoscopic exams, including the condition of tissue and appearance of blood vessels under mucosa. Fujifilm is currently working on joint research efforts with physicians to verify the benefits of this technology in clinical settings and establishes best practices in diagnostic methods.
By developing products that combine these advanced optical, image sensor and image processing technologies, FUJINON and Fujifilm are providing vital support to the diagnostic work of physicians, reducing the physical discomfort for patients, and facilitating the early detection and treatment of lesions. In addition, the companies will continue to contribute to the advance of diagnostic science utilizing image processing in cooperation with leading-edge medical institutions in Japan and overseas.
Comparison of FICE image and standard image
![[Photo]Utilization of FICE highlights area surrounding the inflamed tissues and blood vessels of the esophagus, allowing precise observation and diagnosis.](pack/images/activity_img_08.jpg)
Utilization of FICE highlights area surrounding the inflamed tissues and blood vessels of the esophagus, allowing precise observation and diagnosis.





